Vladimir Coric

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi request reprint Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder
    Vladimir Coric
    Psychopharmacology (Berl) 167:219-20. 2003
  2. ncbi request reprint N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
    Daniel L Lafleur
    Psychopharmacology (Berl) 184:254-6. 2006
  3. ncbi request reprint Systematic review: pharmacological and behavioral treatment for trichotillomania
    Michael H Bloch
    Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Biol Psychiatry 62:839-46. 2007
  4. ncbi request reprint Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial
    Vladimir Coric
    Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, USA
    Biol Psychiatry 58:424-8. 2005
  5. doi request reprint Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder
    Angeli Landeros-Weisenberger
    Yale Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA
    J Affect Disord 121:175-9. 2010
  6. ncbi request reprint Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration
    Rasmon Kalayasiri
    Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 61:1310-3. 2007
  7. doi request reprint Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review
    Michael H Bloch
    Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Am J Med Genet B Neuropsychiatr Genet 147:850-8. 2008
  8. pmc Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms
    Gerard Sanacora
    Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
    Biol Psychiatry 61:822-5. 2007
  9. doi request reprint Long-term outcome in adults with obsessive-compulsive disorder
    Michael H Bloch
    Child Study Center, Yale University, New Haven, Connecticut Department of Psychiatry, Yale University, New Haven, Connecticut
    Depress Anxiety 30:716-22. 2013
  10. pmc Sleep architecture, cocaine and visual learning
    Peter T Morgan
    Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, New Haven, CT 06519, USA
    Addiction 103:1344-52. 2008

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorder
    Vladimir Coric
    Psychopharmacology (Berl) 167:219-20. 2003
  2. ncbi request reprint N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder
    Daniel L Lafleur
    Psychopharmacology (Berl) 184:254-6. 2006
    ..N-acetylcysteine (NAC) is a readily available amino acid compound that is thought to attenuate glutamatergic neurotransmission. NAC may be useful in treating psychiatric disorders involving glutamatergic dysfunction such as OCD...
  3. ncbi request reprint Systematic review: pharmacological and behavioral treatment for trichotillomania
    Michael H Bloch
    Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Biol Psychiatry 62:839-46. 2007
    ..Future therapy and pharmacotherapy studies in trichotillomania should employ larger sample sizes and intention-to-treat analysis and seek to validate clinical rating scales of trichotillomania severity...
  4. ncbi request reprint Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial
    Vladimir Coric
    Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, USA
    Biol Psychiatry 58:424-8. 2005
    ..Recent imaging data suggests glutamatergic dysfunction in the corticostriatal pathway in OCD. We investigated the efficacy of augmentation therapy with riluzole, a glutamate-modulating agent, in treatment-resistant OCD...
  5. doi request reprint Dimensional predictors of response to SRI pharmacotherapy in obsessive-compulsive disorder
    Angeli Landeros-Weisenberger
    Yale Child Study Center, Yale University School of Medicine, New Haven, CT 06520, USA
    J Affect Disord 121:175-9. 2010
    ..Our objective was to replicate these results in OCD patients who participated in one of four randomized, placebo-controlled, clinical trials (RCT)...
  6. ncbi request reprint Dopamine beta-hydroxylase gene (DbetaH) -1021C-->T influences self-reported paranoia during cocaine self-administration
    Rasmon Kalayasiri
    Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 61:1310-3. 2007
    ..Variation in the gene for dopamine beta-hydroxylase (DbetaH) has been reported to associate with cocaine-induced paranoia as assessed by retrospective self-report. This association has yet to be tested prospectively...
  7. doi request reprint Association of the serotonin transporter polymorphism and obsessive-compulsive disorder: systematic review
    Michael H Bloch
    Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Am J Med Genet B Neuropsychiatr Genet 147:850-8. 2008
    ..Further meta-analyses based on individual patient data would be helpful in determining whether age of OCD onset, gender and the presence of comorbid illness (e.g., tics) moderates the relationship between 5-HTTLPR and OCD...
  8. pmc Preliminary evidence of riluzole efficacy in antidepressant-treated patients with residual depressive symptoms
    Gerard Sanacora
    Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut, USA
    Biol Psychiatry 61:822-5. 2007
    ..Recent evidence suggests that riluzole and other agents that target glutamate neurotransmission may show antidepressant activity...
  9. doi request reprint Long-term outcome in adults with obsessive-compulsive disorder
    Michael H Bloch
    Child Study Center, Yale University, New Haven, Connecticut Department of Psychiatry, Yale University, New Haven, Connecticut
    Depress Anxiety 30:716-22. 2013
    ..However, these studies were conducted before validated OCD rating scales were established and the development of evidence-based treatments for OCD...
  10. pmc Sleep architecture, cocaine and visual learning
    Peter T Morgan
    Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, New Haven, CT 06519, USA
    Addiction 103:1344-52. 2008
    ..We hypothesized that sleep-related cognitive function would be impaired in chronic cocaine users, and that this impairment would be associated with abstinence-related changes in sleep architecture...
  11. ncbi request reprint Riluzole in the treatment of mood and anxiety disorders
    Christopher Pittenger
    Clinical Neuroscience Research Unit, Yale University School of Medicine, New Haven, Connecticut, USA
    CNS Drugs 22:761-86. 2008
    ..Riluzole may hold promise for the treatment of several psychiatric conditions, possibly through its ability to modulate pathologically dysregulated glutamate levels, and merits further investigation...
  12. ncbi request reprint A paradigm to investigate the self-regulation of cocaine administration in humans
    Atapol Sughondhabirom
    Department of Psychiatry, Yale University, New Haven, CT 06519, USA
    Psychopharmacology (Berl) 180:436-46. 2005
    ..The current study assessed the feasibility, safety, and validity of a model of ad libitum cocaine self-administration, in which participants self-selected the timing of cocaine infusions, using PCA techniques...
  13. ncbi request reprint Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: Evidence for occult insomnia
    Peter T Morgan
    Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, Clinical Neuroscience Research Unit, 34 Park Street, New Haven, CT 06519, USA
    Drug Alcohol Depend 82:238-49. 2006
    ..However, they report subjectively improving sleep, indicating they are unaware of this "occult" insomnia. These results suggest the possibility of homeostatic sleep drive dysregulation in chronic cocaine users...
  14. ncbi request reprint Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking
    Graeme F Mason
    NIAAA Center for the Translational Neuroscience of Alcoholism and Department of Psychiatry, Yale University, School of Medicine, New Haven, CT 06520, USA
    Biol Psychiatry 59:85-93. 2006
    ..This study's objective was to measure time-dependent cortical GABA levels with sobriety in ethanol-dependent patients with mild to moderate withdrawal severity, controlling for alcoholism-related neurotoxicity and smoking...
  15. doi request reprint Relationships among plasma dehydroepiandrosterone and dehydroepiandrosterone sulfate, cortisol, symptoms of dissociation, and objective performance in humans exposed to underwater navigation stress
    Charles A Morgan
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Biol Psychiatry 66:334-40. 2009
    ....
  16. pmc The impact of burnout on human physiology and on operational performance: a prospective study of soldiers enrolled in the combat diver qualification course
    C A Morgan
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA
    Yale J Biol Med 75:199-205. 2002
  17. pmc Association of polymorphisms in HCN4 with mood disorders and obsessive compulsive disorder
    Benjamin Kelmendi
    Department of Psychiatry, Yale University School of Medicine, 300 George Street, New Haven, CT 06511, United States
    Neurosci Lett 496:195-9. 2011
    ..These findings suggest HCN4 as a genetic susceptibility factor for mood and anxiety disorders; however, these results will require replication using a larger sample...
  18. pmc Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder
    Christopher Pittenger
    Yale University Department of Psychiatry, New Haven, Connecticut 06508, USA
    NeuroRx 3:69-81. 2006
    ..This new application of glutamate modulating agents holds promise for the treatment of this disabling and often inadequately treated disease...
  19. ncbi request reprint Self-reported paranoia during laboratory "binge" cocaine self-administration in humans
    Rasmon Kalayasiri
    Department of Psychiatry, Yale School of Medicine, 34 Park Street, New Haven, CT 06519, USA
    Pharmacol Biochem Behav 83:249-56. 2006
    ..Such methods may facilitate our understanding of the vulnerability to CIP in humans...
  20. ncbi request reprint Relation between cardiac vagal tone and performance in male military personnel exposed to high stress: three prospective studies
    C A Morgan
    Department of Psychiatry, Yale University, New Haven, Connecticut, USA
    Psychophysiology 44:120-7. 2007
    ..The data suggest that vagal suppression is associated with enhanced performance under conditions of high stress and that this enhanced performance may be related to emotion regulation and cognitive functioning...
  21. doi request reprint Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-up
    Christopher Pittenger
    J Clin Psychopharmacol 28:363-7. 2008
  22. ncbi request reprint Riluzole augmentation for treatment-resistant depression
    Gerard Sanacora
    Am J Psychiatry 161:2132. 2004
  23. ncbi request reprint Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania
    Vladimir Coric
    J Clin Psychiatry 68:170-1. 2007
  24. ncbi request reprint Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors
    David A Sasso
    J Clin Psychopharmacol 26:685-7. 2006
  25. ncbi request reprint Visual hallucinations from the addition of riluzole to memantine and bupropion
    Christopher Pittenger
    J Clin Psychopharmacol 26:218-20. 2006
  26. ncbi request reprint Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder
    Christopher Pittenger
    J Clin Psychiatry 66:1492-3. 2005